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Summary
pown's syndrome (OS) is the most common chromosomal
c:ause of mental retardation, and amniocentesis is the most
"ignificant factor affecting its prevalence.
In South Africa, prenatal cytogenetic diagnoses have been
;ivailable for just over a decade and the utilisation and effect
c)f this procedure in the white population born between 1980
;ind 1984 was evaluated.
On the basis of pooled data involving 4939640 births, an
()verall world mean rate for OS of 1,34/1000 live births
(mainly Caucasian) for single-year maternal ages was calcu-
lated. Accordingly, 58 cases of OS were expected in the 40-
~ear and older maternal age group in South Africa. Only 34
cases (59%) were detected prenatally, and a further 3 cases
'iiere identified by the notification system during the same
~eriod and in the same maternal age group.
Another 24 OS cases in the maternal age group of 40 years
<lnd over could thus potentially have been detected prenatally
clnd prevented, while 21 cases in this age group (36%) could
r10t be accounted for at all. Cost-benefit analyses are shown
clnd the number of amniocenteses required for various mater-
r1al age groups to affect the prevention of OS is calculated.
5 Afr Med J 1991; 79: 213-216.
Several factors affect the prevalence of Down's syndrome (DS)
in the general population, such as the increased mortality rate
- especially for DS babies born to :illothers 3S years and
older, compared with those born to younger mothers. l How-
ever, the most significant factor affecting this prevalence has
been the introduction of amniocentesis, a procedure considered
to be safe, accurate and reliable for the prenatal diagnosis of
DS. This test has made the prenatal diagnosis of some 200
genetic conditions possible in most industrialised countries.
In South Africa, prenatal diagnoses have been available for
just over a decade. 2 The Genetic Services (GS) Division
within the Department of National Health and Population
Development (DNHPD) since 1979 enhanced the use of pre-
natal diagnostics for the prevention of genetic abnormalities in
this country.
Owing to the increased risk of DS associated with advanced
maternal age and since amniocentesis involves only a small risk
of spontaneous abortion/ a routine prenatal test was made
available by the DNHPD to all women aged 40 years and
OVer. This age group is considered a practical and 'safe' cut-off
point for the prenatal test and should not burden the available
cytogenetic units to the point where the required laboratory
st:andards cannot be maintained.
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This report examines the ascertainment of individuals with
DS born between 1980 and 1984 in the white population of
South Africa. These data are compared with a calculated
world incidence of DS. It was also one of the objectives of this
study to calculate how many individuals with DS were born to
mothers aged 40 years and older, so that the utilisation of
prenatal cytogenetic diagnosis of DS in this age group during
the period 1980 - 1984 could be evaluated.
Material and methods
Ascertainment of DS by the GS Division of the DNHPD is
attempted for surveillance purposes and to ensure that a
comprehensive genetic service is or has been provided to the
families concerned. This ascertainment rate is not considered
an incidence rate since the ascertainment is incomplete.
'otifications for the surveillance of families with DS are
provided by all agencies concerned with this syndrome, such
as special schools, training centres, care and rehabilitation
centres (CRCs), clinics and DS parent groups. Such notifi-
cations are voluntary and maintained in a central data bank.4
Genetic services are rendered to all population groups in
South Africa. However, only DS cases in the white population
born between 1980 and 1984 were included in this analysis,
since the majority (± 90%) of requests for prenatal diagnosis
had come from members of the white population.
The number of live births among whites, with I-year inter-
vals of maternal age from 1980 to 1984, was obtained from the
State Central Statistical Services (Table I). The total number
of DS cases in South Africa, detected prenatally by cytogenetic
investigations from 1980 to 1984, could be calculated from the
central cytogenetic database kept by the GS Division. This
information was contributed by laboratories of the Department
of Human Genetics at Groote Schuur, Tygerberg and Bloem-
fontein Hospitals, the cytogenetic laboratories at the University
of Pretoria and at MEDUNSA, the Blood Transfusion Service
of Natal, the South African Institute for Medical Research
(SAIMR) in Johannesburg and the DNHPD laboratory at.
Potchefstroom.
For purposes of comparison, a mean rate of DS per 1000
live births for single-year maternal age intervals was calculated
from fooled data from six large studies, i.e. upstate New
York, Ohio,6 British Columbia/ Massachusetts,8 Sweden9-
and Clanmorgan,10 representing 4939640 live births. Data
from the large European collaborative study! 1 and other large
. ·,rud;..~s such as the Atlanta study12 were not included, since
.he:. rates were based on prenatal diagnoses. The other studies
from which the mean rate was calculated apparently reflect
rates calculated before the advent of active prenatal diagnosis.
The DS rate obtained from the amniocentesis figures in the
European collaborative study was compared with the world
DS rate in births, calculated in this study.
The observed rate of DS per 1000 live births is based on
notified, as well as prenatally detected, DS cases. This rate is
compared with an expected DS rate calculated from the
pooled data of 4939640 live births, as well as from the
number of DS cases not ascertained according to the expected
number.
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TABLE I. RATE OF BIRTHS OF OS INFANTS TO WHITE MOTHERS AND EXPECTED RATE ACCORDING TO MATERNAL AGE,
1980 - 1985
Maternal Detected Observed rate' Expected rate Expected No. No. of cases
age No. of births Cases notified prenatally per per of cases observed minus
1 000 births 1 000 births expected
15 590 0,613 0
16 1817 0,55 0,524 1 0
17 4972 0,750 4 -4
18 9503 3 0,32 0,785 7 -4
19 14421 6 0,42 0,657 9 -3
20 19163 5 0,26 0,658 13 -8
21 22684 3 0,13 0,795 16 -13
22 26266 6 0,23 0,633 17 -11
23 28673 12 0,42 0,678 19 -6
24 30718 6 0,20 0,821 25- -19
25 30827 10 0,32 0,795 25 -15
26 30780 10 0,32 0,850 26 -16
27 28992 6 0,21 1,027 30 -24
28 26236 8 0,30 0,912 24 -16
29 23024 12 0,52 0,92 21 -9
30 19549 9 2 0,46 1,247 24 -13
31 16773 9 0,54 1,372 23 -14
32 13534 7 0,52 1,667 23 -15
33 11290 2 0,18 1,936 22 -20
34 8894 6 0,67 2,22 20 -14
35 7131 5 2 0,70 3,104 22 -15
36 5548 5 1 0,90 3,554 20 -14
37 4148 4 3 0,96 4,531 19 -12
38 2913 5 6 1,72 6,079 18 -7
39 2044 3 5 1,47 7,881 16 -8
40 1406 2 4 1,42 10,506 15 -9
41 953 1 4 1,05 11,419 11 -6
42 581 13 15,149 9 +4
43 364 4 19,198 7 -3
44 188 1 29,634 6 -5
45 94 5 34,072 3 +2
46 46 1 52,779 3 -2
47 29 2 51,095 2 -0
48 16 68,313 1 -1












total 394251 200 0,51 1,34 52St -328*
• Calculated from pooled data for single maternal age groups (see text) based on 4 939 640 live births.
t Expected number of OS cases corrected.
* OS observed minus expected corrected..
Results
The total number of binhs according to single-year maternal
age groups in the white population for the 5-year period
1982 - 1984 is given in Table I.
In Table 11 the total number of births for all maternal age
groups, the number of live DS cases notified, the number of
DS cases diagnosed prenatally, the number of amniocenteses
done, and the calculated expected DS rate for age are given on
an annual basis for 1980 - 1984. A total of 200 cases ofDS out
of 384 197 live binhs were identified. In Table III age-specific
rates for DS in the advanced maternal age group ( > 35 years)
(crude rate) compared with rates in live births are pr_esented.
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TABLE 11. DS CASES NOTIAED AFTER BIRTH AND DETECTED BY AMNIOCENTESIS COMPARED WITH EXPECTED RATE
Cases observed
Live-born cases Prenatally Total amniocen- minus cases
Year Births notified diagnosed te'ses done Expected No.' expected
1980 74777 30 7 1235 100 -63
1981 79061 36 13 1355 106 -57
1982 77 686 26 7 1759 104 -71
1983 81 139 23 6 1 920 109 -80
1984 81534 31 21 2193 109 -57
Termi-
nations 54
Total 394261 146 54 8462 528 -328



















































TABLE Ill. AGE-SPECIFIC RATES FOR DS IN ADVANCED MATERNAL AGE GROUP (> 35 YEARS)















• Figures obtained from the European Collaborative Study.
t Figures calculated from pooled data (Table I).
The expected reduced rates in live births compared with rates
during pregnancy are clearly evident.
Discussion
An overall world mean rate of DS per 1000 live births (mainly
among whites) for single-year maternal ages is 1,34, based on
pooled data involving 4939640 births. According to this rate,
the overall mean fractional rate is 1/746 live births, which is
S(lmewhat lower than the rate of 1/600 or 1/650 often cited in
genetic counselling.13, 14
Genetic counsellors mostly consult the rate (risk) for DS in
live births between the maternal age groups over 35 years, and
often the fractional rates are preferred to the decimal rates.
These rates are derived from Table I and are presented in
Table III for the sake of convenience for counsellors. As
e'tpected, rates for DS in pregnancies are somewhat higher
tItan in live-borns and have been included in Table III
(<1.erived from the European Collaborative Study) for easy
r<;ference.
of the DNHPD. The rest (54) were diagnosed prenatally by
amniocentesis and the pregnancies were terminated. The total
of 200 cases give a rate for DS of 0,51/1 000 live births, only
38% of the calculated rate of 1,34/1000 live binhs, which
leaves a total of 328 cases of DS unaccounted for and indicates
an under-reponing of 62%. Under-reponing and under-ascer-
tainment are, however, also experienced in many other
countries, although to a lesser extent.5 As expected, the
majority of prenatally undetected DS cases in the white popu-
lation of SA occurred in the 21 - 36-year age groups (Table I).
This is probably due to the fact that mothers in this age range
do not qualify for a prenatal test, since they are not considered
to be at high risk of having a baby with DS. However, most
babies are .born to mothers in this age group, because it is
considered to be the most fertile period. Although the majority
of DS cases therefore occur in this lower age group, the
incidence per 1000 live births is relatively low.
The method(s) of ascenainment of DS in SA, as is the case
in many other countries, will have to be improved dramatically
for practical prevention purposes.
Ascertainment
One hundred and fony-six of the 200 individuals with DS
OIU of 384 197 live births (white population group; 1980 -1984)
were ascenained by the notification system of the GS Division
Utilisation of prenatal diagnosis
A total of 8462 amniocenteses were done in South Africa
(1980 - 1983) specifically for the prenatal detection of fetuses
with chromosomal abnormalities (Table 11).
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A total of 54 DS fetuses (mothers of all ages) were diagnosed
prenatally, and with a few exceptions the pregnancies were
terminated. Advanced maternal age, i.e. 40 years and older,
was the most common (± 40%) indication for amniocentesis.
As expected, the most common abnormality detected was DS.
In the 40-year and older maternal age group only 34 (59%)
of the expected 58 DS fetuses were detected prenatally. Only a
funher 3 DS cases were identified by the notification system
during the same period and in the same maternal age group.
Another 24 cases could therefore potentially have been detected
prenatally and prevented, while 21 (36%) of cases in this age
group could not be accounted for at all. This trend is also
being experienced in other countries, e.g. in Australia, where
the utilisation rate for high-risk pregnant women aged 40 years
and over was only 38,8% in 1982. 15
According to the expected occurrences rate shown in Table
I, about 11,5% of the expected number of DS cases for all age
groups occurred in maternal age group of 40 years and over. It
is thus estimated that only 5% of the expected number (528) of
DS binhs in SA from 1980 to 1984 were therefore prevented
as a result of prenatal cytogenetic diagnoses.
According to the expected number of DS cases (Table I),
31% of all cases of this syndrome should have occurred in the
maternal age group of 35 years and over, i.e. 19,5% in the
35 - 39 years group. Approximately a further 21000 prenatal
diagnoses in the 35 - 39 years group would have had to be
done during the 5:year period to detect and prevent the binhs
of another expected 95 individuals with DS.
Cost-benefit
The cost to the State of a prenatal cytogenic investigation was
R84, whereas the cost of caring for a child with DS in a CRC
is conservatively calculated at R5000 per year (excluding
approximately R8000 per year for special education). The
care-cost per patient according to the most recent figures
obtained from the Mitchell's Plain eRC in Cape Town is
calculated at roughly RIO 000 per year per patient (excludin~
special education). With a life expectancy of at least 30 years'
and basic expenses of at least R5000 - RIO 000 per year, the
total care-cost per individual amounts to between R150000
and R300 000 (excluding special education).
The cost of prenatal detection of a DS fetus in the maternal
age group of 40 years and over currently amounts to approxi-
mately R3360, based on an estimated 1/40 occurrence rate of
DS in this age group. A national prenatal screening programme
for DS in this age group would therefore undoubtedly be very
cost-effective. It is also indicated that the cost benefit derived
from prenatal screening for DS would still be greater than the
cost of caring for an affected individual even if the maternal
age limit was lowered to 32 years. 5
In the maternal age group of 36 - 40 years, the risk of
having a child with DS is approximately 1/175. At R84 per
test it would cost approximately R23000 to detect one fetus
with DS prenatally in this age interval. However, a screening
programme would still be cost-effective if the financial impli-
cations of such a programme are compared with those of
caring for an affected individual. It must be mentioned that a
price increase to approximately R100 per chromosome test is
expected for the State cytogenetic investigations, which would
affect the cost-benefit accordingly.
A 100% utilisation rate of amniocentesis by all mothers aged
35 years and. older requires laboratory and clinical facilities for
some 24000 amniocenteses per year. To accommodate all
population groups in South Africa, facilities for at least 145000
amniocenteses per year would have to be provided. To accom-
modate only women aged 40 years and older, facilities for
about 18000 amniocenteses would be necessary.
Conclusion
The results presented here show that only approximately 60%
of pregnant women in the age group 40 years and older were
subject to amniocentesis and in fact had the benefit of primary
prevention. This indicates the scope that remains for.a funher
40% of mothers in this age group (white) to be reached.
It is expected that the utilisation rate in other population
groups will be much lower owing to limited awareness and
acceptance of prenatal diagnosis and primary prevention.
With existing cytogenetic laboratories operating at capacity
and with only 2612 amniocenteses being performed in 1986,
the urgent need for appropriate facilities for prenatal cyto-
genetic investigations in South Africa, with approximately 1
million binhs per year, is evident.
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